When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NTEC - Intec Pharma's Accordion Pill for Parkinson's shows positive action in mid-stage study
Intec Pharma Ltd.
Results from an open-label two-way crossover Phase 2 clinical trial evaluating Intec Pharma's (NASDAQ:NTEC) Accordion Pill - Carbidopa/Levodopa (AP-CD/LD) in Parkinson's disease (PD) patients showed a treatment effect. The data were just published in the journal Parkinson's and Related Disorders.
More news on: Intec Pharma Ltd., Healthcare stocks news,